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Preimplantation development shifts from a maternal to embryonic programme rapidly after fertilization. Although the majority
of oogenetic products are lost during the maternal to embryonic transition (MET), several do survive this interval to contribute
directly to supporting preimplantation development. Embryonic genome activation (EGA) is characterized by the transient
expression of several genes that are necessary for MET, and while EGA represents the first major wave of gene expression, a
second mid-preimplantation wave of transcription that supports development to the blastocyst stage has been discovered. The
application of genomic approaches has greatly assisted in the discovery of stage specific gene expression patterns and the challenge
now is to largely define gene function and regulation during preimplantation development. The basic mechanisms controlling com-
paction, lineage specification and blastocyst formation are defined. The requirement for embryo culture has revealed plasticity in
the developmental programme that may exceed the adaptive capacity of the embryo and has fostered important research direc-
tions aimed at alleviating culture-induced changes in embryonic programming. New levels of regulation are emerging and greater
insight into the roles played by RNA-binding proteins and miRNAs is required. All of this research is relevant due to the necessity
to produce healthy preimplantation embryos for embryo transfer, to ensure that assisted reproductive technologies are applied in
the most efficient and safest way possible.
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Introduction
These are exciting times for mammalian preimplantation developmen-
tal biology. An unprecedented group of molecular tools are available
for probing the molecular mechanisms that control preimplantation
development. Studies have employed gene arrays and proteomics to
define gene expression during preimplantation development leading
to an astounding production of data that define the molecular pro-
gramme controlling the first week of development. Our knowledge
of the mechanisms controlling gene expression during this period
has also increased exponentially with discoveries implicating chroma-
tin remodelling, acetylation, methylation, transcription, deadenyla-
tion, RNA-binding proteins (RBPs), microRNAs, translation and
protein phosphorylation as critical instruments that the early embryo
employs to regulate its first week of development. Corresponding
with these developments, is our increasing capacity to define specific
gene function during preimplantation development by applying gene
targeting, transgenics, down-regulation of gene expression by appli-
cation of antisense and siRNA approaches and gain of function by
injection of cRNAs. Collectively these advances have begun to
unravel the secrets of preimplantation development, primarily in the
mouse, but increasingly in other species such as the cow, sheep, pig
and even the human.
These advances in our ability to define the mechanisms controlling
preimplantation development are timely, as the necessity for under-
standing these mechanisms has never been greater, with our increasing
application of assisted reproductive technologies to promote reproduc-
tion in humans and other important species such as livestock and also
to endangered species to ensure their survival. In addition, there is not
only a great need to characterize normal development, but to also
understand the effects of exposure to abnormal culture environments
on preimplantation development. This is necessary, since the pro-
duction of embryos from all mammalian species requires the
removal of either gametes and/or embryos from the reproductive
tract. This requirement has fostered a research enterprise that has
led to the understanding that the gene expression patterns of cultured
embryos can vary quite significantly from that of in vivo derived
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embryos. We are concerned about these differences because research
has correlated these differences with abnormalities that range from
early embryo loss to placental defects, fetal growth abnormalities
and even increased susceptibility to disease in later life. Thus, it is
imperative that we understand the mechanisms controlling normal
development and also to assess the adaptive capacity of cultured
embryos so that we can increasingly be assured that the environments
within which we place gametes and embryos will not exceed these
adaptive capacities and result in the dire consequences presented
above.
The purpose of this review is to summarize our current understand-
ing of the gene expression patterns that arise during preimplantation
development and review our current understanding of the mechanisms
that control mRNA expression and stability during early development.
We will also introduce emerging areas of research interest including
microRNAs and RBP control of mRNA stability and translation. We
will briefly consider the effects of culture environment on gene
expression patterns and mechanisms controlling gene expression.
The field has expanded so rapidly that we do not claim to be compre-
hensive in this single review. The reader, if interested, should also be
directed to several other excellent recent reviews on this topic that
understandably emphasize other aspects of this topic to greater or
lesser extents than the present review covers (Gandolfi and Gandolfi,
2001; Schultz, 2005; Bettegowda et al., 2008).
Genomic profiling of mRNA pools during
preimplantation development
Preimplantation development includes the free-living period of mam-
malian development extending from the 1-cell zygote to blastocyst
attachment or implantation into the uterine wall (Fig. 1). It generally
encompasses the first week of development and includes critical
events such as the transition from maternal to embryonic genome acti-
vation (EGA), compaction, and cavitation or blastocyst formation.
The main accomplishment of preimplantation development is to
produce an implantation-competent embryo for the initiation of preg-
nancy. To accomplish this goal, the very first epithelium, the trophec-
toderm (TE), must form, as this epithelium becomes the outer layer of
the blastocyst, and interacts with the endometrium to initiate implan-
tation. The TE is also the progenitor of the embryonic component of
the placenta. A second cell type that remains pluripotent, the inner
cell mass (ICM), is the progenitor of the embryo proper. These cells
remain enclosed in the blastocyst surrounded by both mural and
polar TE. Thus, preimplantation development is not primarily con-
cerned with embryogenesis but rather TE differentiation, for placental
mammals must first conquer this requirement for implantation and pla-
cental development before embryogenesis can proceed.
Recent studies have completely transformed our approach to study-
ing gene expression during early development by bringing the global
perspective that gene arrays can bring to gene expression studies
(Dobson et al., 2004; Hamatani et al., 2004; Tanaka and Ko, 2004;
Wang et al., 2004; Misirlioglu et al., 2006; Rinaudo et al., 2006; Gir-
itharan et al., 2007; Vallee et al., 2008). Three groups published stage
specific gene array analysis of gene expression in mouse preimplanta-
tion embryos in 2004 (Hamatani et al., 2004; Wang et al., 2004; Zeng
et al., 2004; Fig. 1). Hamatani et al. (2004) employed an NIA 60-mer
oligo microarray, enriched in stem cells and preimplantation stage
embryo transcripts, while Wang et al. (2004) and Zeng et al. (2004)
used Affymetrix 25-mer DNA microarray systems. Even more
recent studies use the new mouse Affymetrix 430 2.0 array that is
Figure 1: Characterization of global gene expression patterns during preimplantation development.
Three groups published stage specific gene array analysis of gene expression in mouse preimplantation embryos in 2004 (Hamatani et al., 2004; Wang et al., 2004;
Zeng et al., 2004). Two main waves of gene expression were observed corresponding with EGA and a second MGA that contributed to events associated with TE
differentiation and blastocyst formation (Hamatani et al., 2004). Hamatani et al. (2004), Wang et al. (2004) and Zeng et al. (2004) are landmark studies in the charac-
terization of gene expression patterns during preimplantation development as they have produced extensive catalogues of global stage specific gene expression pat-
terns. General gene expression patterns are indicated; loss of maternal mRNAs (red); activation of embryonic genome (green); MGA (purple) and continuous
expression (orange). Examples of genes expressed in each category are indicated in boxes.
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believed to cover the complete mouse genome (Giritharan et al.,
2007). Hamatani et al. (2004) reported that 12 179/21 939 genes dis-
played a significant change in expression during mouse preimplanta-
tion development. Wang et al. (2004) found that over 4000 genes
changed in expression over 5-fold during development and evidence
that the expression of a large number of genes was regulated at the
transcription, adenylation or mRNA half-life levels. Two main
waves of gene expression were observed corresponding with EGA
and a second mid-preimplantation gene activation (MGA) that con-
tributed to events associated with TE differentiation and blastocyst
formation (Hamatani et al., 2004; Fig. 1). Thus, Hamatani et al.
(2004), Wang et al. (2004) and Zeng et al. (2004) are landmark
studies in the characterization of gene expression patterns during pre-
implantation development as they have produced extensive catalogues
of global stage specific gene expression patterns. The challenge in the
field now has moved from asking whether a particular gene is
expressed and when during preimplantation development; to under-
standing what factors affect its expression and what function does it
contribute to preimplantation development. Global gene expression
analysis has also been applied to contrast gene expression between
cultured and in vivo derived mouse embryos (Rinaudo et al., 2006;
Giritharan et al., 2007); to examine the effects of oxygen atmosphere
on mouse preimplantation embryo gene expression patterns (Rinaudo
et al., 2006); and has been extended to contrast global gene expression
profiles in other species such as the cow (Sirard et al., 2005; Misirlio-
glu et al., 2006), pig (Whitworth et al., 2005) and the human preim-
plantation embryo (Dobson et al., 2004). Future applications of this
technology will include contrasting gene expression between wild-
type and gene deleted or knocked down ovaries or embryos (Murchi-
son et al., 2005; Shin et al., 2005; Joshi et al., 2007) and in antagonist
and agonist treatment experiments to determine the specific influences
of individual regulatory genes and signalling pathways in controlling
gene expression during preimplantation development. We must
however increase our bioinformatic capacity to efficiently process
all the information generated by these types of experiments and to a
certain degree we must begin to think more along the lines of
‘systems biology’ where we consider the implications that result
from affecting gene pools rather than outcomes based upon single
gene analysis. This represents a large challenge for future develop-
ments in this field.
Maternal to embryonic transition and EGA
We will now focus attention to the mechanisms controlling mRNA
transcript abundance during early development. Our discussion
begins in the oocyte as oocyte cytoplasmic maturation is required to
complete nuclear maturation, fertilization and preimplantation devel-
opment and thus provides a foundation for implantation, initiation of
pregnancy and fetal development (Gandolfi and Gandolfi, 2001; Sirard
et al., 2006). Oocyte cytoplasmic maturation includes the storage of
mRNAs, proteins, substrates and nutrients that result in the attainment
of oocyte developmental competence that ensures embryonic develop-
mental competence (Gandolfi and Gandolfi, 2001; Krisher, 2004;
Sirard et al., 2006). Transcription and storage of maternal mRNA
occurs during follicular growth but ceases as the germinal vesicle
undergoes breakdown during meiosis (Brevini-Gandolfi et al., 1999;
Gandolfi and Gandolfi, 2001; Fair et al., 2004). The embryo is depen-
dent on stored maternal mRNA until at least the maternal–zygotic
transition, when transcription of embryonic genes begins with a
major burst occurring at the 2-cell stage in mice (Flach et al., 1982;
Brevini-Gandolfi et al., 1999; Gosden, 2002; Schultz, 2002). One of
the greatest mysteries of the mammalian developmental programme
is why is it necessary to store and accumulate mRNAs and proteins
during oogenesis to simply then activate a programme that results
largely in their demise shortly after fertilization within the first few
cleavage divisions? Degradation of maternal mRNA stores and
mRNA deadenylation shortly after fertilization results in a dramatic
turnover of maternal mRNA during early cleavage stages with up to
a 40% decline in bulk maternal RNA and up to a 70% decrease in
maternal poly Aþ mRNA (Bachvarova and De Leon, 1980; Piko
and Clegg, 1982; Fig. 1). Of that decrease in poly Aþ mRNA,
some is degraded and some is deadenylated (Bachvarova, 1985;
Paynton et al., 1988). Many of the maternal messages degraded
immediately after fertilization are likely detrimental to further devel-
opment (Alizadeh et al., 2005). For example, c-mos is an important
factor for oocyte maturation and is present from the oocyte to ferti-
lized oocyte (Paules et al., 1989). However, when c-mos mRNA
was reintroduced into Xenopus 2-cell embryo, developmental arrest
resulted (Sagata et al., 1989). Most of the maternal mRNAs that
decline early after fertilization contain a cytoplasmic polyadenylation
element (CPE) close to the nuclear poly Aþ signal in the 30UTR (Oh
et al., 2000; Alizadeh et al., 2005).
It is challenging to determine whether disappearance of mRNAs is
due to degradation or deadenylation. Many protocols use oligo(dT) for
reverse transcription; however, mRNAs without a long enough poly
Aþ tail are inefficiently transcribed (Schultz et al., 1999; Lequarre
et al., 2004; Schultz, 2005), thus polyadenylation of a message may
increase its detection level (Wang et al., 2004, Zeng et al., 2004). In
addition, some procedures only capture poly Aþ mRNA (Wrenzycki
et al., 1999; Gutierrez-Adan et al., 2004; Tanaka and Ko, 2004; Shin
et al., 2005) and deadenylated mRNAs will be underrepresented in the
sample (Lequarre et al., 2004; Thelie et al., 2007). Underrepresenta-
tion of deadenylated messages could also be a problem when using
oligo(dT) amplification for generating microarray data (Su et al.,
2007; Thelie et al., 2007). Therefore, absence or reduction in particu-
lar maternal mRNAs must be confirmed to occur by degradation by
northern blotting, or reverse transcription with gene-specific (Bach-
varova, 1985; Oh et al., 2000; Alizadeh et al., 2005), random
primers (Su et al., 2007; Thelie et al., 2007). It is critical that these
methodological approaches be applied in tandem to decipher the con-
tributions of adenlyation status to overall transcript stability (Paynton
et al., 1988; Paynton and Bachvarova 1994; Oh et al., 2000).
Despite the low rates of transcription at the 1-cell stage, recruitment
and polyadenylation of maternal mRNAs likely results in the higher
detection of 1500 transcripts in 1-cell embryos than other stages (Oh
et al., 2000). On the other hand, most of the highly up-regulated
genes at the 2-cell stage are newly transcribed (Zeng and Schultz,
2005; Fig. 1). Furthermore, polyadenylation is closely linked in time
with translation (Huarte et al., 1987; Stutz et al., 1998; Oh et al.,
2000). Timely translation of maternal mRNAs provides the coordi-
nation of protein synthesis required for the maternal to embryonic
transition (MET) (Oh et al., 2000). In general, polyadenylation is
associated with translational activation, while deadenylation is associ-
ated with translational silencing (Oh et al., 2000; Piccioni et al., 2005).
Polyadenylation and translation are controlled mostly by regions in the
50 and 30UTRs (reviewed by (Piccioni et al., 2005)). Silencing or
masking factors bind to mRNAs and keep them from being translated
(Stutz et al., 1998; Gosden, 2002). These factors are likely to be post-
translationally modified to allow dissociation from mRNAs to allow
their later translation (Schultz, 1993; Stutz and Rosbash, 1998).
Maternal mRNAs with long poly Aþ tails but lacking a U-rich CPE
are deadenylated by default during oocyte maturation. Some tran-
scripts with shorter poly Aþ tails are stable. While others, such as
hypoxanthine-quanidine phosphoribosyl transferase, with a CPE and
a short poly Aþ tail are polyadenylated during maturation. Studies
in this field have extended to also investigate the influences of
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varying culture environments on mRNA deadenylation and mRNA
turnover/stability (Brevini-Gandolfi et al., 1999; Gandolfi and Gan-
dolfi, 2001; Vigneault et al., 2007).
It would appear that the mammalian preimplantation developmental
programme has evolved to ensure that the EGA occurs very early in
development, and thus from the first cleavage divisions onward, the
embryo assumes a great control over its own developmental fate by
the expression of gene products from its own genome (Fig. 1).
Despite this being the general pattern, it would be inaccurate to
suggest that maternal transcripts serve little role in ensuring develop-
ment proceeds properly in mammalian embryos, as not all maternal
gene products are degraded during the MET, some are degraded
later at the mouse 4- and 8-cell stages and are probably necessary
for the EGA (Hamatani et al., 2004). Up to 10% of labelled maternal
mRNAs persist until the blastocyst stage of development (Bachvarova
and De Leon, 1980), and thus could have a critical role that extends
beyond ensuring that EGA proceeds in an optimal fashion. Several
important recent studies have defined several maternal gene products
that are required to support early development such as Stella, (also
known as developmental pluripotency associated 3, Dppa3 (Payer
et al., 2003)), MATER (maternal product that embryos require, also
known as Nalp5 (Tong et al., 2000a,b)), Zar1 (Zygote arrest 1 (Wu
et al., 2003a,b)) and ZFP36L2 (a tristetraprolin-like RBP family
member (Ramos et al., 2004; Fig. 1)). These are all dispensable for
growth up to the mature follicle stage, and embryo development is
affected in gene knock-outs.
Embryonic genome activation
Early studies suggested that EGA represented a global and promiscu-
ous activation of genes whose regulated repression was then necess-
ary to establish the preimplantation developmental programme
(Schultz, 1993; Ma et al., 2001). More recent transcriptomic analyses
have demonstrated that EGA is in fact a highly regulated gene
expression programme (Hamatani et al., 2004; Wang et al., 2004;
Zeng et al., 2004). Genes involved in transcription and RNA metab-
olism are overrepresented at the EGA (Zeng et al., 2004). Evidence
suggests that most of the newly synthesized EGA transcripts are
quickly translated (Flach et al., 1982). Epigenetic chromatin remo-
delling is now proposed as the main mechanism via which the
EGA occurs, where epigenetic marks involve post-translational
modifications (methylation, acetylation, phosphorylation and ubiqui-
tination) of nucleosomal histones, DNA methylation and non-histone
proteins that bind to chromatin. In general, transcriptionally inactive
heterochromatin is characterized by deacetylated histones, methyl-
ation of histone H3 lysine 9 and DNA methylation, whereas acety-
lation of H3 and H4 histones, methylation of histone H3 lysine 4
and low level of DNA methylation are associated with active gene
expression. These modifications alter the chromatin structure to
provide access for the regulatory transcriptional factors that control
gene expression. Interestingly, demethylation and remethylation
events are not uniform across all species, and differences are seen
between pig, cow, sheep, mice and even humans. For an excellent
review on chromatin remodelling in the early embryo, see Fulka
et al. (2008).
In the mouse, the pattern that has been defined is one where at fer-
tilization, the maternal genome is packaged with histones already
displaying various modifications (acetylation or methylation) in
different regions of the genome and a high level of DNA methyl-
ation. In the paternal pronucleus, protamines are first replaced with
histones that are more acetylated than those inherited by the maternal
genome but evidence of early histone methylation appears soon after
this incorporation. An active demethylation of the paternal DNA then
occurs before DNA replication and only some specific regions of
heterochromatin around centromeres, inhibitor of apoptosis (IAP)
retrotransposons and paternally methylated imprinted genes escape
it (Morgan et al., 2005). Both parental genomes are thus epigeneti-
cally unique, which may underlie the early transcriptional activation
of the paternal genome. Following fertilization, the entire embryonic
genome undergoes a passive DNA demethylation resulting in a
largely demethylated genome by the morula stage (Morgan et al.,
2005). Methylation of the genome reasserts itself at the blastocyst
stage.
In recent years, several genes have been identified as having a role
in EGA. These include genes that regulate early transcription of the
zygotic genome, RNA stabilization up to the 2-cell stage as well as
genes involved in RNA translation at the 2-cell stage (Fig. 1). For
example, Zscan4 is exclusively expressed in late 2-cell embryos as
well as embryonic stem (ES) cells (Falco et al., 2007). Zscan4
mRNA is highly expressed at the 2-cell stage but not expressed at
all at the 3-cell stage indicating that it has a very short half-life and
is only transiently expressed. Functional analysis of Zscan4 using
RNAi knock-down revealed that Zscan4 is indeed important for the
2-cell stage progression to the 4-cell stage, timely progression to the
blastocyst stage, proper blastocyst hatching and implantation (Falco
et al., 2007). Furthermore, Zscan4 knock-down embryos showed
reduced ability to hatch from the zona pellucida, and when reintro-
duced into the uterus of pseudo-pregnant females, they were unable
to implant compared with control-injected embryos (Falco et al.,
2007).
One of the first chromatin remodelling genes to be identified during
early development is a maternally derived transcript called BRG1,
also known as Smarca4 (SWI/SNF-related, matrix-associated, actin-
dependent regulator of chromatin, subfamily a, member 4) (Bultman
et al., 2006). BRG1 is the enzymatic subunit of the SWI/SNF
complex and BRG1 null embryos display preimplantation embryo
lethality and die at the blastocyst stage (Bultman et al., 2000;
Bultman et al., 2006). However, heterozygous females are able to
accumulate maternal transcripts of BRG1 which may support develop-
ment and survival to the blastocyst stage. BRG1 conditional knock-
outs produce oocytes that develop normally, and could be fertilized,
which indicates that BRG1 did not affect oocyte maturation or ferti-
lity. However, 78% of the maternally depleted BRG1 embryos
arrest at the 2-cell stage compared with only 3% of control embryos
(Bultman et al., 2006). Transcription was also reduced in BRG1
maternally depleted embryos by up to 30% (Bultman et al., 2006).
Genes involved in cell cycle, transcription and mRNA processing
were particularly affected including the transcription-requiring
complex, an accepted marker of EGA (Schultz, 2002). The SWI/
SNF complex is involved in chromatin remodelling via histone modi-
fication, therefore changes in dimethyl H3K4 were investigated due to
its correlation with transcriptional activity (Bultman et al., 2006).
Maternally depleted embryos of BRG1 showed a 61% reduction in
dimethylated H3K4 compared with controls (Bultman et al., 2006).
For successful MET, we must also consider the importance of RNA
translation, not just transcription. Recently, peptidyl arginine deimi-
nase 6 (PADI6) was found to associated with oocyte cytoplasmic lat-
tices (CPLs) (Yurttas et al., 2008). PADI6 plays a role in establishing
or maintaining the CPL, which in turn affects ribosome localization at
the 2-cell stage (Yurttas et al., 2008). Padi6 2/2 females are infertile,
and although the oocytes can be fertilized, they block at the 2-cell
stage. Furthermore, CPLs do not form in the oocyte, which indicates
that they may be playing a role in EGA. Padi6 2/2 embryos
expressed lower levels of total rRNA compared with control
embryos, and as a result, proper genome activation was disrupted
(Yurttas et al., 2008). These results underscore the importance of
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lattice structures in the developing embryo and, in particular, have
identified a gene, PADI6, directly involved in correct EGA. These
are but a few examples of the exciting discoveries that are defining
the global and specific mechanisms controlling genome activation in
the early embryo. Following EGA, the embryos proceed with the
next major event that establishes cell polarity in the outer embryonic
blastomeres and triggers the programme that supports the differen-
tiation of these cells into the epithelial TE.
Lineage specification during preimplantation
development
Embryo compaction represents the first morphogenetic indication of
cell lineage specification in the early embryo. Despite the intriguing
possibility that even 2-cell blastomeres may display asymmetries
and some level of cell lineage bias (Piotrowska et al., 2001; Plusa
et al., 2005), compaction is still coincident with the loss of blastomere
totipotency and the initiation of the TE developmental programme.
Compaction is defined by an increase in cell-to-cell contact between
embryonic blastomeres. It is promoted by the establishment of adhe-
rens junctions consisting of E-cadherin and catenin complexes
(Fleming et al., 2000; Johnson and McConnell, 2004). Compaction
is initiated at the 8-cell stage in the mouse but the timing varies
across species (Telford et al., 1990). In all cases, compaction results
in the formation of a morula, which creates a topology that forms
outer cells and inner cells that are completely surrounded by the
outer cells, which are the progenitors of the TE and ICM, respectively
(Fleming et al., 2000; Johnson and McConnell, 2004). The main
model that defines this event is called ‘the cell polarity model’ (Tar-
kowski and Wroblewska, 1967; Johnson and Ziomek, 1981). The
cell polarity model predicts that cell fate is established at the 8-cell
stage in the mouse and propagated by symmetrical or asymmetrical
cell divisions that either generate two polar cells by dividing a
radial polarity axis or an outer polar and an inner apolar cell
(Johnson and McConnell, 2004; Yamanaka et al., 2006). Adherens
junction components, the PAR complex (PAR 1, 3 and 6), atypical
protein kinase C and tight junction-associated proteins are key
mediators of these events, but what factors actually regulate lineage
specification in the early embryo? Recent research applied to the
mouse has established that TE and ICM differentially express
several lineage-specific transcription factors (Fig. 2). Cdx2 becomes
restricted to the TE and is required for TE formation (Yamanaka
et al., 2006). In contrast, Oct4 and Nanog become restricted to and
influence ICM fate (Yamanaka et al., 2006; Fig. 2). This research
has led to the formation of a model that proposes mutual antagonism
between Oct4 and Cdx2 in supporting the formation of TE and ICM
fates in the blastocyst (Yamanaka et al., 2006). The focus of research
in this area is now directed at understanding the target genes that these
transcription factors control and how these transcription factors regu-
late the cell fate of ES cell lines.
Our research has been directed at understanding the mechanisms
that control blastocyst formation, which is dependent upon TE
differentiation, as it is the ion and water transport functions of the
TE that mediate the fluid dynamics that control cavitation (Watson
et al., 1992; Watson and Barcroft, 2001; Fig. 2). Na/K-ATPase,
aquaporins (AQPs; water channels) and tight junction proteins
have established roles in coordinating blastocyst formation
(Watson et al., 1992; Watson and Barcroft, 2001). Our model pre-
dicts that blastocyst formation is dependent upon the polarized dis-
tribution of the Na/K-ATPa1b1ase confined to the basolateral
membrane domains of the TE (Fig. 2). This establishes a trans-TE
ion gradient that facilitates movement of water across the epithelium
facilitated by the presence of both apical and basolateral AQPs
(Fig. 2). These events combined with the establishment of a TE
tight junctional seal to prevent the loss of fluid out of the embryo
through paracellular routes result in the expansion of the embryo
and the formation of the blastocyst (Kidder and McLachlin, 1985;
Watson and Barcroft, 2001).
Figure 2: Preimplantation embryo cell lineage specification and blastocyst formation model.
Recent research applied to the mouse has established that TE and ICM differentially express several lineage-specific transcription factors. Cdx2 becomes restricted to
the TE and is required for TE formation (Yamanaka et al., 2006). In contrast, Oct4 and Nanog become restricted to and influence ICM fate (Yamanaka et al., 2006).
This research supports a model that proposes mutual antagonism between Oct4 and Cdx2 in supporting the formation of TE and ICM fates in the blastocyst
(Yamanaka et al., 2006). Our research has been directed at understanding the mechanisms that control blastocyst formation, which is dependent upon TE differ-
entiation, as it is the ion and water transport functions of the TE that mediate the fluid dynamics that control cavitation (Watson et al., 1992; Watson and Barcroft,
2001). Na/K-ATPase, AQP (water channels) and tight junction (TJ) proteins have established roles in coordinating blastocyst formation (Watson et al., 1992;
Watson and Barcroft, 2001). Our model predicts that blastocyst formation is dependent upon the polarized distribution of the Na/K-ATPa1b1ase confined to
the basolateral membrane domains of the TE. This establishes a trans-TE ion gradient that facilitates movement of water across the epithelium facilitated by
the presence of both apical and basolateral AQPs. These events combined with the establishment of a TE tight junctional seal to prevent the loss of fluid out of
the embryo through paracellular routes result in the expansion of the embryo and the formation of the blastocyst (Watson and Barcroft, 2001) E-cad, E-cadherin;
NHE-3, sodium–hydrogen exchanger 3.
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Na/K-ATPase enzyme activity increases just prior to blastocyst for-
mation (Watson et al., 1992; Watson and Barcroft, 2001). The
expression of all principal Na/K-ATPase isozymes has been deter-
mined, as well as the functions of Na/K-ATPase a1 and b1 subunits
in supporting blastocyst formation in the mouse (Watson et al., 1990;
MacPhee et al., 2000; Barcroft et al., 2004; Madan et al., 2007). In
addition, AQPs and their role in facilitating blastocyst formation in
the mouse have been investigated (Barcroft et al., 2003; Offenberg
and Thomsen, 2005). Interestingly, ATP1b1 and Aqp8 mRNAs were
two of the genes up-regulated during the 4- to 8-cell stages (Hamatani
et al., 2004), many hours prior to the morphological changes of compac-
tion. Aqp8 mRNA is also down-regulated in cultured mouse blastocysts
compared with in vivo derived blastocysts in several microarray studies
(Rinaudo and Schultz, 2004; Rinaudo et al., 2006; Giritharan et al.,
2007) as were Aqp3 and 9 (Giritharan et al., 2007).
In addition to these critical gene products, recent studies have
uncovered additional waves of gene expression, one of which is
now called the MGA, which includes 3329 genes whose expression
first increase at the 4- and 8-cell stages (Hamatani et al., 2004).
A further characterization of TS versus ES cells indicated that genes
such as Gata3, IRX3, EndoA, Bmp8b, Sin 3b and Gata6 are all
more highly expressed in TS cells than in ES cells, indicating that
they may play specific roles in TE cell differentiation (Tanaka et al.,
2002; Hamatani et al., 2004). Among the other genes up-regulated
during the MGA were several tight junction, gap junction, Na/
K-ATPase and AQP gene family members (Hamatani et al., 2004).
Genes up-regulated from the morula to blastocyst stages included
skeletal development/morphogenesis, lipid binding, glucose metab-
olism/energy pathway, actin binding/cytoskeletal and steroid
metabolism genes (Hamatani et al., 2004; Tanaka and Ko, 2004;
Zeng et al., 2004). Thus, the array studies have been invaluable in con-
firming the physiological and molecular data implicating ion transpor-
ters, cell junctions and water channels in mediating blastocyst
formation and have also identified many other important candidates
that must now be investigated to define their functional contributions
to preimplantation development, TE differentiation and blastocyst
formation.
Thus, the principal challenge that remains is to place all of these
stage specific gene expression patterns into a functional context
during preimplantation development. Fortunately, there have been
great advances made in recent years to apply RNA silencing
methods and injection of cRNAs into early embryos to explore both
loss and gain of function to identify gene function in the early
embryo. In addition, the development and characterization of specific
and potent pharmacological agents that target specific gene function
and signalling pathways have been invaluable in defining gene func-
tion during preimplantation development. We have applied both strat-
egies for investigating the role of Na/K-ATPase subunits and also
mitogen-activated protein kinase pathway (MAPK) function during
preimplantation development. Our studies have determined that
siRNA knock-down of the Na/K-ATPase b1 subunit results in a block-
ade of development at the morula stage, as only 3% of b1 subunit
down-regulated embryos undergo cavitation (Madan et al., 2007).
The application of pharmacological approaches using cytokine sup-
pressive anti-inflammatory drugs (CSAIDs) has resulted in our identi-
fication of the p38 MAPK pathway as having both an essential role in
supporting preimplantation development and also a regulatory role to
allow the embryo to respond to exposure to stressful culture environ-
ments (Natale et al., 2004; Paliga et al., 2005; Fong et al., 2007;
Hickson et al., 2007). Treatment of 2- or 8-cell embryos with active
CSAID results in a reversible blockade of development at the 8- to
16-cell stage (Natale et al., 2004; Paliga et al., 2005). This blockade
is associated with a loss of filamentous actin in each blastomere,
which reforms following removal of the CSAID from the culture
medium allowing the resumption of normal development to the blas-
tocyst stage (Paliga et al., 2005). In addition, increasing the osmolarity
of culture medium increased p38 MAPK pathway activation (Fong
et al., 2007). We have also used a similar approach to discover that
p38 MAPK increases AQP 3 and 9 expression (mRNA and protein)
in response to hyperosmotic stress, but only when the medium is
made hyperosmotic with sucrose and not with glycerol (Bell and
Watson, unpublished results). These types of studies highlight
approaches that are required to explore and define gene function
during preimplantation development. Methods for defining gene func-
tion during preimplantation development are now readily available
and future studies must focus on taking the information acquired
from genomic studies of gene expression patterns and translating
them into a functional understanding of the precise roles played by
these genes during preimplantation development. This information
is required to fully understand and develop ways of assessing embryo-
nic developmental potential prior to embryo transfer. This ability must
be developed, as it represents the main breakthrough for human IVF
practitioners to fully implement strategies such as single embryo trans-
fer to promote healthy singleton pregnancies following the application
of assisted reproductive technologies to treat infertility.
Influence of culture on embryonic transcripts
and preimplantation programming
The application of assisted reproductive technologies to all mamma-
lian species requires the exposure of gametes and early embryos to
culture environments. There has been a concerted effort applied to
constant improvement of culture environments since embryo culture
was first developed in the early 1960s; however, even with all of the
advances and improvements, culture conditions have not been fully
optimized for any mammalian species including the mouse to date.
While it is possible to achieve impressive frequencies of development
to the blastocyst stage for a variety of mammalian species in vitro,
blastocyst development does not represent the ideal end-point for
assessing culture influences on development. One of most profound
new understandings that has emerged from studies conducted over
the past 15 years is that cultured embryos display significant
changes in their gene expression patterns and these changes affect
not only survival during the preimplantation period but also affect
the ability of the embryo to implant, proceed normally through fetal
development and also post-partum health and susceptibility to
disease in later life. It is imperative that the mechanisms underlying
these effects of culture on development be defined and the knowledge
obtained from such an understanding be applied directly to improving
embryo culture further. This is especially relevant considering the
need to apply single embryo blastocyst transfer in human assisted
reproductive procedures to reduce the incidence of multiple pregnan-
cies that often are associated with low birthweight infants and prema-
ture delivery. The literature is replete with studies that have now
documented significant changes in mRNA transcript levels in cultured
versus in vivo derived embryos. These effects of culture have been
studied and documented in a variety of mammalian species including
the human, and have also been extended to oocyte maturation in
addition to culture influences on in vivo matured and fertilized, cul-
tured zygotes (Watson et al., 2000; Lonergan et al., 2003; Russell
et al., 2006).
While the documentation of these differences in transcript levels
between cultured and in vivo derived embryos is sound, the interpret-
ation and understanding of the functional significance of these changes
is not well understood. It is necessary to correlate these changes in
gene expression with pregnancy outcomes. While this is
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understandably very difficult to do, El-Sayed et al. (2006) conducted
an experiment where the relationship between the transcriptional pro-
files of embryos measured in cell biopsies was correlated with preg-
nancy outcome. The results indicated that embryos that successfully
generated pregnancies and successful fetuses displayed up-regulated
expression of genes necessary for implantation (COX2, CDX2),
carbohydrate metabolism (ALOX15), growth factor (BMP15), signal
transduction (PLAU) and placental development (PLAC8), while
embryos that failed to generate a pregnancy overexpressed inflamma-
tory cytokines (TNF), protein amino acid binding (EEF1A1), tran-
scription factors (MSX1, PTTG1) and glucose metabolism genes
(El-Sayed et al., 2006). We have highlighted this study as it indicates
the need for extending experimental end-points to fully assess and
understand the impact of exposure to culture environments on
embryonic and fetal programming.
Our efforts in this regard have begun to focus on understanding the
mechanisms and signalling pathways that preimplantation embryos
activate in response to exposure to culture environments (Fig. 3).
There is an assumption in the literature that the majority of variations
in gene expression patterns observed between cultured and in vivo
derived embryos are a consequence of changes in gene transcription.
However, it is equally likely that these changes stem from variations in
the mechanisms that cells employ to regulate mRNA stability and
half-life (Fig. 3). Thus, our research efforts are now being directed
towards understanding the role of RBPs during preimplantation
development, so that we may test the hypothesis that the culture-
induced changes in mRNA abundance are regulated by RBP-mediated
changes in target mRNA stability (Fig. 3). These studies will not only
address culture-induced mechanisms controlling gene expression in
the early embryo, but also will increase our understanding of
mRNA transcript regulation in general during preimplantation
development.
Regulation of mRNA transcripts during
preimplantation development—RBPs
RBPs influence RNA editing, localization, stability and translation
(Saunders and Barber, 2003). Moreover, regulated mRNA stability
occurs in mammalian cells in response to nutrient levels, hormones
and environmental stresses such as hypoxia and fluctuations in temp-
erature and misregulation may occur in cancer or disease (reviewed by
Guhaniyogi and Brewer, 2001). Up to 380 RBPs have been identified
in the mouse genome (McKee et al., 2005). Except for MSY2 and
DAZL, there has been little research on the role of mammalian
RBPs in mammalian oocytes or early embryos (Ruggiu et al., 1997;
Yu et al., 2003; Yang et al., 2005). MSY2 compromises 2% of
total protein in the mouse oocyte. Both MSY2 mRNA and protein
are degraded by the mouse 2-cell stage (Yu et al., 2001). In female
MSY2 knock-out mice, there is early loss of follicles and oocytes, a
lack of ovulation and infertility (Yang et al., 2005). MSY2 is likely
to be a major control of maternal mRNA stability and translation in
mice (Yu et al., 2001). DAZL is a member of the DAZ gene family
(deleted in azoospermia), first identified in infertile men (Reijo
et al., 1995), and has a role in regulating translation in germ cells
(Collier et al., 2005). Female mouse knock-outs of DAZL have no fol-
licles or oocytes and are infertile, while homozygous knock-out males
have an absence of germ cells and even heterozygous males have
reduced sperm counts and sperm abnormalities (Ruggiu et al.,
1997). This suggests that the mammalian RBP DAZL is important
for germ cell survival.
We have determined that several RBPs are expressed during both
mouse and cow early embryonic development including Staufens 1
and 2 (STAU1 and STAU2), embryonic lethal abnormal vision-like
1 and 2 (ELAVL1 and ELAVL2, previously known as HuR, HuB),
spermatid perinuclear RNA-binding protein (STRBP), deleted in
Figure 3: MAPK regulation of RBPs and control of mRNA stability.
We are investigating the hypothesis that exposure to stressful environments activates p38MAPK activity in preimplantation embryos which in turn regulates RBP
(Elavl1, ZFP36 and KHSRP) activity and the stability of their target mRNAs (GCLC and SLC2a1). This mechanism may be among the principal routes that pre-
implantation embryos utilize to adapt to exposure to changing environments and may contribute to the variation in mRNA levels that are reported to occur due to
placement of embryos into suboptimal culture environments.
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azoospermia-like (DAZL), CUG triplet repeat RNA-binding protein 1
(CUGBP1, previously known as CUG-BP, EDEN-BP), smaug
(SAMD4), zing finger protein 36 (ZFP36, previously known as triste-
traprolin or TTP) and KH-type splicing regulatory protein (KHSRP)
(Calder et al., unpublished results; Calder et al., 2008).
These results are important because studies have determined that
ELAVL1, ZFP36 and KHSRP RBPs are downstream targets of p38
MAPK a/b signalling and that they bind to AU-rich elements
(AREs) in the 30UTR of target mRNAs, a process that results in
either stabilization or turnover of target mRNAs (Lal et al., 2004;
Raineri et al., 2004; Briata et al., 2005; Fechir et al., 2005; Linker
et al., 2005; Song et al., 2005; Chen et al., 2006; Cherry et al.,
2006; Chou et al., 2006; Gantt et al., 2006; Marderosian et al.,
2006; Fig. 3). Regulation of mRNA turnover is a critical component
determining abundance of mRNA transcripts and thus regulation of
gene expression in general (Piccioni et al., 2005). The best character-
ized cis-elements controlling mRNA stability are the AREs (Lal et al.,
2004; Raineri et al., 2004; Chen et al., 2006). AREs orchestrate exo-
somal degradation of mRNAs. mRNAs containing AREs are usually
rapidly turned over in resting cells but are readily stabilized through
interactions with 30UTR-binding RBPs (Lal et al., 2004; Raineri
et al., 2004; Linker et al., 2005; Chen et al., 2006). Several RBPs
that bind to AREs and regulate mRNA turnover have been identified.
ELAV RBPs bind to AREs and stabilize mRNA transcripts (Lal et al.,
2004; Song et al., 2005; Chen et al., 2006), while ZFP36 and KHSRP
RBPs also bind to AREs but instead promote the rapid decay of
mRNA transcripts (Briata et al., 2005; Fechir et al., 2005; Linker
et al., 2005; Chen et al., 2006; Chou et al., 2006; Marderosian
et al., 2006). Increased cytoplasmic localization of ELAVL1 protein
is associated with increased oxidative stress and enhanced
MAPKAPK2/3 phosphorylation (Lal et al., 2004; Raineri et al.,
2004; Cherry et al., 2006).
Studies have indicated that ZFP36 phosphorylation is regulated by
p38 MAPK signalling and that phosphorylated ZFP36 displays
reduced RNA-binding activity associated with reduced target
mRNA degradation (Fechir et al., 2005; Song et al., 2005; Mardero-
sian et al., 2006). The ZFP36 gene has been knocked out in mice;
however, the main phenotype is arthritis and there is no reported
reproductive phenotype (Taylor et al., 1996). Our results indicate an
increase in expression at the mouse 4-cell stage (Calder et al., unpub-
lished results). However, in the knockout of a ZFP36 family member,
ZFP36L2, nulls are infertile because embryos block at the 2-cell stage
(Ramos et al., 2004). Because of these interesting features, ZFP36
family members should be more thoroughly investigated in the early
mouse embryo, their roles are likely to be in degradation of maternal
mRNAs.
KHSRP also regulates mRNA turnover by binding to AREs, and
interactions with the exosome and deadenylases (Linker et al., 2005;
Chou et al., 2006). Studies have determined that stability of target
mRNAs (iNOS) is increased when KHSRP is immunodepleted and
that KHSRP co-immunoprecipitates with ZFP36 on target mRNAs
and also competes directly with ELAVL1 for ARE-binding sites on
target mRNAs (Linker et al., 2005; Chou et al., 2006). In addition,
KHSRP is phosphorylated by p38 MAPK and its phosphorylation is
accompanied by reduced binding to target mRNAs and increased
target mRNA stability (Linker et al., 2005; Chou et al., 2006).
We are testing a model that predicts that ZFP36 and KHSRP may
therefore oppose ELAVL1 binding and that p38 MAPK a/b signalling
may increase mRNA stability by both reducing ZFP36 and KHSRP
binding and increasing ELAVL1 cytoplasmic distribution (Fechir
et al., 2005; Song et al., 2005; Marderosian et al., 2006; Fig. 3).
Our results demonstrate that gene products encoding these RBPs are
present in mouse oocytes and early embryos. Furthermore, two
microarray studies have shown that abundance of several RBP
mRNAs and mRNA processing and metabolism are affected by
culture (Whitworth et al., 2005; Giritharan et al., 2007). The proposed
studies will establish a foundation for investigating the roles of RBPs
during early development and, more importantly, their collective roles
in regulating mRNA transcripts during early embryogenesis. We
predict that this route is one of the primary mechanisms being affected
in embryonic responses to culture environment and alteration of
mRNA half-life likely represents a fundamental mechanism control-
ling undesired changes in preimplantation embryo and fetal
programming.
MicroRNAs
In addition to transcription, adenylation, deadenylation, methylation,
acetylation and RBPs, the discovery of hundreds of microRNAs
(miRNAs—20–22 nucleotides) as regulators of post-transcriptional
events has defined yet another level of mRNA regulation that could
have a major impact on defining the programme controlling preim-
plantation development (Blakaj and Lin, 2008; Kedde and Agami,
2008). These short mRNAs have the ability to target and regulate
the stability and translation of individual and pools of target
mRNAs, thus are likely to have profound effects on embryonic gene
expression patterns. Interest in this area began following investigation
of the mouse phenotype resulting from the deletion of Dicer 1, an
enzyme required for miRNA production in cells. One study which
generated Dicer nulls by homologous recombination showed that
embryos failed to progress to the 2-cell stage (Murchison et al.,
2005; Tang et al., 2007), and the lack of miRNAs resulted in persist-
ence of maternal mRNAs. However, knock-down of Dicer by siRNA
did not result in early embryonic lethality, and embryos developed to
the blastocyst stage but with reduced expression of OCT3/4, Nanog
and SOX2 transcription factors (Cui et al., 2007) that may have con-
tributed to later mortality and loss of stem cells seen in an earlier study
(Bernstein et al., 2003). In zebrafish, miRNA-430 is one of the most
abundant miRNAs, with hundreds of possible targets, and accumulates
at the MET (Giraldez et al., 2006). When Dicer was knocked out,
miRNA-430 is not present and maternal transcripts were not deadeny-
lated and degraded in a timely fashion (Giraldez et al., 2006). We
believe that the investigation of the functions of specific miRNAs rep-
resents an important new avenue for understanding the mechanisms
controlling early development. The possibility becomes even more
intriguing when one considers that recent studies have demonstrated
that RBPs and miRNAs may co-operate with or counteract each
other to control transcript stability and translation (Kedde and
Agami, 2008; Yu and Hecht, 2008). These truly are exciting times
for this type of research.
Summary
The preimplantation developmental programme shifts from a maternal
to embryonic programme rapidly after fertilization. Although the
majority of oogenetic products are lost during the MET, several do
survive this interval to contribute directly to supporting preimplantation
development. EGA is characterized by the transient expression of a few
genes that are likely necessary for MET, and while EGA represents the
first major wave of gene expression, there are several more, including
the MGA, that supports development to the blastocyst stage. These
events are regulated by changes in chromatin remodelling that include
variations in DNA methylation and histone acetylation. The application
of genomic approaches have greatly assisted in the discovery of stage
specific gene expression patterns and the challenge now is to largely
define gene function and regulation during preimplantation
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development. The basic mechanisms controlling compaction, lineage
specification and blastocyst formation are defined; however, much
more knowledge is required to understand how the specific gene pro-
ducts controlling these events are regulated and the function of most
genes is not understood to date. The requirement for embryo culture
has revealed plasticity in the developmental programme that may
exceed the adaptive capacity of the embryo and has fostered important
research directions aimed at alleviating culture-induced changes in
embryonic programming. New levels of regulation are emerging and
greater insight into the roles played by RBPs and miRNAs is required
to fully understand the regulation of transcript stability and translation
during preimplantation development. All of this exciting research is rel-
evant due to the necessity to produce healthy and competent preimplan-
tation embryos for embryo transfer, to ensure that assisted reproductive
technologies are applied in the most efficient and safest way possible.
Funding
Unpublished studies conducted by the authors and referred to in this
review were supported by research operating funds obtained from
the Natural Sciences and Engineering Research Council (NSERC)
of Canada and the Canadian Institutes of Health Research (CIHR)
awarded to AJW.
References
Alizadeh Z, Kageyama S, Aoki F. Degradation of maternal mRNA in mouse
embryos: selective degradation of specific mRNAs after fertilization. Mol
Reprod Dev 2005;72:281–290.
Bachvarova R. Gene expression during oogenesis and oocyte development in
mammals. Dev Biol (N Y 1985) 1985;1:453–524.
Bachvarova R, De Leon V. Polyadenylated RNA of mouse ova and loss of
maternal RNA in early development. Dev Biol 1980;74:1–8.
Barcroft LC, Offenberg H, Thomsen P, Watson AJ. Aquaporin proteins in
murine trophectoderm mediate transepithelial water movements during
cavitation. Dev Biol 2003;256:342–354.
Barcroft LC, Moseley AE, Lingrel JB, Watson AJ. Deletion of the Na/
K-ATPase alpha1-subunit gene (Atp1a1) does not prevent cavitation of the
preimplantation mouse embryo. Mech Dev 2004;121:417–426.
Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, Li MZ, Mills AA,
Elledge SJ, Anderson KV, Hannon GJ. Dicer is essential for mouse
development. Nat Genet 2003;35:215–217.
Bettegowda A, Lee KB, Smith GW. Cytoplasmic and nuclear determinants
of the maternal-to-embryonic transition. Reprod Fertil Dev 2008;20:
45–53.
Blakaj A, Lin H. Piecing together the mosaic of early mammalian development
through microRNAs. J Biol Chem 2008;283:9505–9508.
Brevini-Gandolfi TA, Favetta LA, Mauri L, Luciano AM, Cillo F, Gandolfi F.
Changes in poly(A) tail length of maternal transcripts during in vitro
maturation of bovine oocytes and their relation with developmental
competence. Mol Reprod Dev 1999;52:427–433.
Briata P, Forcales SV, Ponassi M, Corte G, Chen CY, Karin M, Puri PL,
Gherzi R. p38-dependent phosphorylation of the mRNA decay-promoting
factor KSRP controls the stability of select myogenic transcripts. Mol Cell
2005;20:891–903.
Bultman S, Gebuhr T, Yee D, La Mantia C, Nicholson J, Gilliam A, Randazzo
F, Metzger D, Chambon P, Crabtree G et al. A Brg1 null mutation in the
mouse reveals functional differences among mammalian SWI/SNF
complexes. Mol Cell 2000;6:1287–1295.
Bultman SJ, Gebuhr TC, Pan H, Svoboda P, Schultz RM, Magnuson T.
Maternal BRG1 regulates zygotic genome activation in the mouse. Genes
Dev 2006;20:1744–1754.
Calder MD, Madan P, Watson AJ. Bovine oocytes and early embryos
express Staufen and ELAVL RNA-binding proteins. Zygote 2008;16:
161–168.
Chen YL, Huang YL, Lin NY, Chen HC, Chiu WC, Chang CJ. Differential
regulation of ARE-mediated TNFalpha and IL-1beta mRNA stability by
lipopolysaccharide in RAW264.7 cells. Biochem Biophys Res Commun
2006;346:160–168.
Cherry J, Karschner V, Jones H, Pekala PH. HuR, an RNA-binding protein,
involved in the control of cellular differentiation. In Vivo 2006;20:
17–23.
Chou CF, Mulky A, Maitra S, LinWJ, Gherzi R, Kappes J, Chen CY. Tethering
KSRP, a decay-promoting AU-rich element-binding protein, to mRNAs
elicits mRNA decay. Mol Cell Biol 2006;26:3695–3706.
Collier B, Gorgoni B, Loveridge C, Cooke HJ, Gray NK. The DAZL family
proteins are PABP-binding proteins that regulate translation in germ cells.
EMBO J 2005;24:2656–2666.
Cui XS, Shen XH, Kim NH. Dicer1 expression in preimplantation mouse
embryos: involvement of Oct3/4 transcription at the blastocyst stage.
Biochem Biophys Res Commun 2007;352:231–236.
Dobson AT, Raja R, Abeyta MJ, Taylor T, Shen S, Haqq C, Pera RA. The
unique transcriptome through day 3 of human preimplantation
development. Hum Mol Genet 2004;13:1461–1470.
El-Sayed A, Hoelker M, Rings F, Salilew D, Jennen D, Tholen E, Sirard MA,
Schellander K, Tesfaye D. Large-scale transcriptional analysis of bovine
embryo biopsies in relation to pregnancy success after transfer to
recipients. Physiol Genomics 2006;28:84–96.
Fair T, Murphy M, Rizos D, Moss C, Martin F, Boland MP, Lonergan P.
Analysis of differential maternal mRNA expression in developmentally
competent and incompetent bovine two-cell embryos. Mol Reprod Dev
2004;67:136–144.
Falco G, Lee SL, Stanghellini I, Bassey UC, Hamatani T, Ko MS. Zscan4: a
novel gene expressed exclusively in late 2-cell embryos and embryonic
stem cells. Dev Biol 2007;307:539–550.
Fechir M, Linker K, Pautz A, Hubrich T, Forstermann U, Rodriguez-Pascual F,
Kleinert H. Tristetraprolin regulates the expression of the human inducible
nitric-oxide synthase gene. Mol Pharmacol 2005;67:2148–2161.
Flach G, Johnson MH, Braude PR, Taylor RA, Bolton VN. The transition from
maternal to embryonic control in the 2-cell mouse embryo. EMBO J
1982;1:681–686.
Fleming TP, Ghassemifar MR, Sheth B. Junctional complexes in the early
mammalian embryo. Semin Reprod Med 2000;18:185–193.
Fong B, Watson PH, Watson AJ. Mouse preimplantation embryo responses to
culture medium osmolarity include increased expression of CCM2 and p38
MAPK activation. BMC Dev Biol 2007;7:2–17.
Fulka H, St. John JC, Fulka J, Hozak P. Chromatin in early mammalian
embryos: achieving the pluripotent state. Differentiation 2008;76:3–14.
Gandolfi TA, Gandolfi F. The maternal legacy to the embryo: cytoplasmic
components and their effects on early development. Theriogenology
2001;55:1255–1276.
Gantt KR, Cherry J, Richardson M, Karschner V, Atasoy U, Pekala PH. The
regulation of glucose transporter (GLUT1) expression by the RNA binding
protein HuR. J Cell Biochem 2006;99:565–574.
Giraldez AJ, Mishima Y, Rihel J, Grocock RJ, Van Dongen S, Inoue K, Enright
AJ, Schier AF. Zebrafish miRNA-430 promotes deadenylation and clearance
of maternal mRNAs. Science 2006;312:75–79.
Giritharan G, Talbi S, Donjacour A, Di Sebastiano F, Dobson AT, Rinaudo PF.
Effect of in vitro fertilization on gene expression and development of mouse
preimplantation embryos. Reproduction 2007;134:63–72.
Gosden RG. Oogenesis as a foundation for embryogenesis. Mol Cell
Endocrinol 2002;186:149–153.
Guhaniyogi J, Brewer G. Regulation of mRNA stability in mammalian cells.
Gene 2001;265:11–23.
Gutierrez-Adan A, Rizos D, Fair T, Moreira PN, Pintado B, de la Fuente J,
Boland MP, Lonergan P. Effect of speed of development on mRNA
expression pattern in early bovine embryos cultured in vivo or in vitro.
Mol Reprod Dev 2004;68:441–448.
Hamatani T, Carter MG, Sharov AA, Ko MS. Dynamics of global gene
expression changes during mouse preimplantation development. Dev Cell
2004;6:117–131.
Hickson JA, Fong B, Watson PH, Watson AJ. PP2Cdelta (Ppm1d, WIP1), an
endogenous inhibitor of p38 MAPK, is regulated along with Trp53 and
Cdkn2a following p38 MAPK inhibition during mouse preimplantation
development. Mol Reprod Dev 2007;74:821–834.
Huarte J, Belin D, Vassalli A, Strickland S, Vassalli JD. Meiotic maturation
of mouse oocytes triggers the translation and polyadenylation of
dormant tissue-type plasminogen activator mRNA. Genes Dev 1987;1:
1201–1211.
Johnson MH, McConnell JM. Lineage allocation and cell polarity during
mouse embryogenesis. Semin Cell Dev Biol 2004;15:583–597.
Johnson MH, Ziomek CA. Induction of polarity in mouse 8-cell blastomeres:
specificity, geometry, and stability. J Cell Biol 1981;91:303–308.
Embryonic function at the RNA level
699
Joshi S, Davies H, Sims LP, Levy SE, Dean J. Ovarian gene expression in the
absence of FIGLA, an oocyte-specific transcription factor. BMC Dev Biol
2007;7:67–79.
Kedde M, Agami R. Interplay between microRNAs and RNA-binding proteins
determines developmental processes. Cell Cycle 2008;7:899–903.
Kidder GM, McLachlin JR. Timing of transcription and protein synthesis
underlying morphogenesis in preimplantation mouse embryos. Dev Biol
1985;112:265–275.
Krisher RL. The effect of oocyte quality on development. J Anim Sci
2004;82(E-Suppl):E14–E23.
Lal A, Mazan-Mamczarz K, Kawai T, Yang X, Martindale JL, Gorospe M.
Concurrent versus individual binding of HuR and AUF1 to common labile
target mRNAs. EMBO J 2004;23:3092–3102.
Lequarre AS, Traverso JM, Marchandise J, Donnay I. Poly(A) RNA is reduced
by half during bovine oocyte maturation but increases when meiotic arrest is
maintained with CDK inhibitors. Biol Reprod 2004;71:425–431.
Linker K, Pautz A, Fechir M, Hubrich T, Greeve J, Kleinert H. Involvement of
KSRP in the post-transcriptional regulation of human iNOS
expression-complex interplay of KSRP with TTP and HuR. Nucleic Acids
Res 2005;33:4813–4827.
Lonergan P, Rizos D, Gutierrez-Adan A, Moreira PM, Pintado B, de la Fuente
J, Boland MP. Temporal divergence in the pattern of messenger
RNA expression in bovine embryos cultured from the zygote to blastocyst
stage in vitro or in vivo. Biol Reprod 2003;69:1424–1431.
Ma J, Svoboda P, Schultz RM, Stein P. Regulation of zygotic gene activation in
the preimplantation mouse embryo: global activation and repression of gene
expression. Biol Reprod 2001;64:1713–1721.
MacPhee DJ, Jones DH, Barr KJ, Betts DH, Watson AJ, Kidder GM.
Differential involvement of Na(þ), K(þ)-ATPase isozymes in
preimplantation development of the mouse. Dev Biol 2000;222:486–498.
Madan P, Rose K, Watson AJ. Na/K-ATPase beta1 subunit expression
is required for blastocyst formation and normal assembly of trophectoderm
tight junction-associated proteins. J Biol Chem 2007;282:12127–12134.
Marderosian M, Sharma A, Funk AP, Vartanian R, Masri J, Jo OD, Gera JF.
Tristetraprolin regulates Cyclin D1 and c-Myc mRNA stability in response
to rapamycin in an Akt-dependent manner via p38 MAPK signaling.
Oncogene 2006;25:6277–6290.
McKeeAE,Minet E, Stern C, Riahi S, Stiles CD, Silver PA.A genome-wide in situ
hybridization map of RNA-binding proteins reveals anatomically restricted
expression in the developing mouse brain. BMC Dev Biol 2005;5:14–22.
Misirlioglu M, Page GP, Sagirkaya H, Kaya A, Parrish JJ, First NL, Memili E.
Dynamics of global transcriptome in bovine matured oocytes and
preimplantation embryos. Proc Natl Acad Sci USA 2006;103:18905–18910.
Morgan HD, Santos F, Green K, Dean W, Reik W. Epigenetic reprogramming
in mammals. Hum Mol Genet 2005;14:R47–R58.
Murchison EP, Partridge JF, TamOH, Cheloufi S, Hannon GJ. Characterization
of Dicer-deficient murine embryonic stem cells. Proc Natl Acad Sci USA
2005;102:12135–12140.
Natale DR, Paliga AJ, Beier F, D’souza SJ, Watson AJ. p38 MAPK signaling
during murine preimplantation development. Dev Biol 2004;268:76–88.
Offenberg H, Thomsen PD. Functional challenge affects aquaporin mRNA
abundance in mouse blastocysts. Mol Reprod Dev 2005;71:422–430.
Oh B, Hwang S,McLaughlin J, Solter D, Knowles BB. Timely translation during
the mouse oocyte-to-embryo transition. Development 2000;127:3795–3803.
Paliga AJ, Natale DR, Watson AJ. p38 mitogen-activated protein kinase
(MAPK) first regulates filamentous actin at the 8–16-cell stage during
preimplantation development. Biol Cell 2005;97:629–640.
Paules RS, Buccione R, Moschel RC, Vande Woude GF, Eppig JJ. Mouse Mos
protooncogene product is present and functions during oogenesis. Proc Natl
Acad Sci USA 1989;86:5395–5399.
Payer B, Saitou M, Barton SC, Thresher R, Dixon JP, Zahn D, Colledge WH,
Carlton MB, Nakano T, Surani MA. Stella is a maternal effect gene required
for normal early development in mice. Curr Biol 2003;13:2110–2117.
Paynton BV, Bachvarova R. Polyadenylation and deadenylation of maternal
mRNAs during oocyte growth and maturation in the mouse. Mol Reprod
Dev 1994;37:172–180.
Paynton BV, Rempel R, Bachvarova R. Changes in state of adenylation and time
course of degradation of maternal mRNAs during oocyte maturation and early
embryonic development in the mouse. Dev Biol 1988;129:304–314.
Piccioni F, Zappavigna V, Verrotti AC. Translational regulation during
oogenesis and early development: the cap-poly(A) tail relationship. C R
Biol 2005;328:863–881.
Piko L, Clegg KB. Quantitative changes in total RNA, total poly(A), and
ribosomes in early mouse embryos. Dev Biol 1982;89:362–378.
Piotrowska K, Wianny F, Pedersen RA, Zernicka-Goetz M. Blastomeres
arising from the first cleavage division have distinguishable fates in
normal mouse development. Development 2001;128:3739–3748.
Plusa B, Hadjantonakis AK, Gray D, Piotrowska-Nitsche K, Jedrusik A,
Papaioannou VE, Glover DM, Zernicka-Goetz M. The first cleavage
of the mouse zygote predicts the blastocyst axis. Nature 2005;434:
391–395.
Raineri I, Wegmueller D, Gross B, Certa U, Moroni C. Roles of AUF1
isoforms, HuR and BRF1 in ARE-dependent mRNA turnover studied by
RNA interference. Nucleic Acids Res 2004;32:1279–1288.
Ramos SB, Stumpo DJ, Kennington EA, Phillips RS, Bock CB, Ribeiro-Neto F,
Blackshear PJ. The CCCH tandem zinc-finger protein Zfp36l2 is crucial for
female fertility and early embryonic development. Development
2004;131:4883–4893.
Reijo R, Lee TY, Salo P, Alagappan R, Brown LG, Rosenberg M, Rozen S,
Jaffe T, Straus D, Hovatta O. Diverse spermatogenic defects in humans
caused by Y chromosome deletions encompassing a novel RNA-binding
protein gene. Nat Genet 1995;10:383–393.
Rinaudo P, Schultz RM. Effects of embryo culture on global pattern of gene
expression in preimplantation mouse embryos. Reproduction
2004;128:301–311.
Rinaudo PF, Giritharan G, Talbi S, Dobson AT, Schultz RM. Effects of oxygen
tension on gene expression in preimplantation mouse embryos. Fertil Steril
2006;86:1252–1265.
Ruggiu M, Speed R, Taggart M, McKay SJ, Kilanowski F, Saunders P, Dorin J,
Cooke HJ. The mouse Dazla gene encodes a cytoplasmic protein essential for
gametogenesis. Nature 1997;389:73–77.
Russell DF, Baqir S, Bordignon J, Betts DH. The impact of oocyte maturation
media on early bovine embryonic development. Mol Reprod Dev
2006;73:1255–1270.
Sagata N,Watanabe N, VandeWoude GF, Ikawa Y. The c-mos proto-oncogene
product is a cytostatic factor responsible for meiotic arrest in vertebrate eggs.
Nature 1989;342:512–518.
Saunders LR, Barber GN. The dsRNA binding protein family: critical roles,
diverse cellular functions. FASEB J 2003;17:961–983.
Schultz RM. Regulation of zygotic gene activation in the mouse. Bioessays
1993;15:531–538.
Schultz RM. The molecular foundations of the maternal to zygotic transition in
the preimplantation embryo. Hum Reprod Update 2002;8:323–331.
Schultz RM. From egg to embryo: a peripatetic journey. Reproduction
2005;130:825–828.
Schultz RM, DavisW Jr, Stein P, Svoboda P. Reprogramming of gene expression
during preimplantation development. J Exp Zool 1999;285:276–282.
Shin SY, Lee HJ, Ko DS, Lee HC, ParkWI. The regulators of VEGF expression
in mouse ovaries. Yonsei Med J 2005;46:679–686.
Sirard MA, Dufort I, Vallee M, Massicotte L, Gravel C, Reghenas H,
Watson AJ, King WA, Robert C. Potential and limitations of bovine-
specific arrays for the analysis of mRNA levels in early development:
preliminary analysis using a bovine embryonic array. Reprod Fertil Dev
2005;17:47–57.
Sirard MA, Richard F, Blondin P, Robert C. Contribution of the oocyte to
embryo quality. Theriogenology 2006;65:126–136.
Song IS, Tatebe S, Dai W, Kuo MT. Delayed mechanism for induction of
gamma-glutamylcysteine synthetase heavy subunit mRNA stability by
oxidative stress involving p38 mitogen-activated protein kinase signaling.
J Biol Chem 2005;280:28230–28240.
Stutz F, Rosbash M. Nuclear RNA export. Genes Dev 1998;12:3303–3319.
Stutz A, Conne B, Huarte J, Gubler P, Volkel V, Flandin P, Vassalli JD.
Masking, unmasking, and regulated polyadenylation cooperate in the
translational control of a dormant mRNA in mouse oocytes. Genes Dev
1998;12:2535–2548.
Su Y-Q, Sugiura K, Woo Y, Wigglesworth K, Kamdar S, Affourtit J, Eppig JJ.
Selective degradation of transcripts during meiotic maturation of mouse
oocytes. Dev Biol 2007;302:104–117.
Tanaka TS, Ko MS. A global view of gene expression in the preimplantation
mouse embryo: morula versus blastocyst. Eur J Obstet Gynecol Reprod
Biol 2004;115(Suppl 1):S85–S91.
Tanaka TS, Kunath T, KimberWL, Jaradat SA, Stagg CA, Usuda M, Yokota T,
Niwa H, Rossant J, Ko MSH. Gene profiling of embryo-derived stem cells
reveals candidate genes associated with pluripotency and lineage
specificity. Genome Res 2002;12:1921–1928.
Tang F, Kaneda M, O’Carroll D, Hajkova P, Barton SC, Sun YA, Lee C,
Tarakhovsky A, Lao K, Surani MA. Maternal microRNAs are essential for
mouse zygotic development. Genes Dev 2007;21:644–648.
Bell et al.
700
Tarkowski AK, Wroblewska J. Development of blastomeres of mouse eggs
isolated at the 4- and 8-cell stage. J Embryol Exp Morphol 1967;18:
155–180.
Taylor GA, Carballo E, Lee DM, Lai WS, Thompson MJ, Patel DD,
Schenkman DI, Gilkeson GS, Broxmeyer HE, Haynes BF et al.
A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis,
and autoimmunity resulting from tristetraprolin (TTP) deficiency.
Immunity 1996;4:445–454.
Telford NA, Watson AJ, Schultz GA. Transition from maternal to embryonic
control in early mammalian development: a comparison of several species.
Mol Reprod Dev 1990;26:90–100.
Thelie A, Papillier P, Pennetier S, Perreau C, Traverso JM, Uzbekova S,
Mermillod P, Joly C, Humblot P, Dalbies-Tran R. Differential regulation
of abundance and deadenylation of maternal transcripts during bovine
oocyte maturation in vitro and in vivo. BMC Dev Biol 2007;7:125–137.
Tong ZB, Gold L, Pfeifer KE, Dorward H, Lee E, Bondy CA, Dean J, Nelson
LM.Mater, a maternal effect gene required for early embryonic development
in mice. Nat Genet 2000a;26:267–268.
Tong ZB, Nelson LM, Dean J. Mater encodes a maternal protein in mice with a
leucine-rich repeat domain homologous to porcine ribonuclease inhibitor.
Mamm Genome 2000b;11:281–287.
Vallee M, Aiba K, Piao Y, Palin MF, Ko MS, Sirard MA. Comparative analysis
of oocyte transcript profiles reveals a high degree of conservation among
species. Reproduction 2008;135:439–448.
Vigneault C, Gilbert I, Sirard MA, Robert C. Using the histone H2a transcript
as an endogenous standard to study relative transcript abundance during
bovine early development. Mol Reprod Dev 2007;74:703–715.
Wang QT, Piotrowska K, Ciemerych MA, Milenkovic L, Scott MP, Davis RW,
Zernicka-Goetz M. A genome-wide study of gene activity reveals
developmental signaling pathways in the preimplantation mouse embryo.
Dev Cell 2004;6:133–144.
Watson AJ, Barcroft LC. Regulation of blastocyst formation. Front Biosci
2001;6:D708–D730.
Watson AJ, Damsky CH, Kidder GM. Differentiation of an epithelium: factors
affecting the polarized distribution of Naþ,K(þ)-ATPase in mouse
trophectoderm. Dev Biol 1990;141:104–114.
Watson AJ, Kidder GM, Schultz GA. How to make a blastocyst. Biochem Cell
Biol 1992;70:849–855.
Watson AJ, De Sousa P, Caveney A, Barcroft LC, Natale D, Urquhart J,
Westhusin ME. Impact of bovine oocyte maturation media on oocyte
transcript levels, blastocyst development, cell number, and apoptosis. Biol
Reprod 2000;62:355–364.
Whitworth KM, Agca C, Kim JG, Patel RV, Springer GK, Bivens NJ, Forrester
LJ, Mathialagan N, Green JA, Prather RS. Transcriptional profiling of pig
embryogenesis by using a 15-K member unigene set specific for pig
reproductive tissues and embryos. Biol Reprod 2005;72:1437–1451.
Wrenzycki C, Herrmann D, Carnwath JW, Niemann H. Alterations in the
relative abundance of gene transcripts in preimplantation bovine embryos
cultured in medium supplemented with either serum or PVA. Mol Reprod
Dev 1999;53:8–18.
Wu X, Viveiros MM, Eppig JJ, Bai Y, Fitzpatrick SL, Matzuk MM. Zygote
arrest 1 (Zar1) is a novel maternal-effect gene critical for the
oocyte-to-embryo transition. Nat Genet 2003a;33:187–191.
Wu X,Wang P, Brown CA, Zilinski CA, MatzukMM. Zygote arrest 1 (Zar1) is
an evolutionarily conserved gene expressed in vertebrate ovaries. Biol
Reprod 2003b;69:861–867.
Yamanaka Y, Ralston A, Stephenson RO, Rossant J. Cell and molecular
regulation of the mouse blastocyst. Dev Dyn 2006;235:2301–2314.
Yang J, Medvedev S, Yu J, Tang LC, Agno JE, Matzuk MM, Schultz RM,
Hecht NB. Absence of the DNA-/RNA-binding protein MSY2 results in
male and female infertility. Proc Natl Acad Sci USA 2005;102:5755–5760.
Yu Z, Hecht NB. The DNA/RNA-binding protein, translin, binds
microRNA122a and increases its in vivo stability. J Androl 2008;29:
572–579.
Yu J, Hecht NB, Schultz RM. Expression of MSY2 in mouse oocytes and
preimplantation embryos. Biol Reprod 2001;65:1260–1270.
Yu J, Hecht NB, Schultz RM. Requirement for RNA-binding activity of MSY2
for cytoplasmic localization and retention in mouse oocytes. Dev Biol
2003;255:249–262.
Yurttas P, Vitale AM, Fitzhenry RJ, Cohen-Gould L, Wu W, Gossen JA,
Coonrod SA. Role for PADI6 and the cytoplasmic lattices in ribosomal
storage in oocytes and translational control in the early mouse embryo.
Development 2008;135:2627–2636.
Zeng F, Schultz RM. RNA transcript profiling during zygotic gene activation in
the preimplantation mouse embryo. Dev Biol 2005;283:40–57.
Zeng F, Baldwin DA, Schultz RM. Transcript profiling during preimplantation
mouse development. Dev Biol 2004;272:483–496.
Submitted on September 5, 2008; resubmitted on October 24, 2008; accepted
on October 27, 2008
Embryonic function at the RNA level
701
